ALEC Alector, Inc.


$ 3.05 $ -0.18 (-5.59 %)    

Friday, 17-Oct-2025 15:59:59 EDT
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 3.04
$ 3.16
$ 2.90 x 100
$ 3.37 x 100
$ 3.03 - $ 3.33
$ 0.87 - $ 6.14
1,043,296
na
307.69M
$ 1.59
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 4-biotechnology-stocks-lead-momentum-gains-amid-strong-technicals

4 biotech stocks—ALDX, ALEC, BDTX, CHRS—show strong week-on-week momentum ranking gains and improving technical indicators.

 btig-reiterates-buy-on-alector-maintains-5-price-target

BTIG analyst Thomas Shrader reiterates Alector (NASDAQ: ALEC) with a Buy and maintains $5 price target.

 top-4-biotech-stocks-set-for-a-breakout-momentum-scores-surge

Several biotech stocks are showing renewed strength over the past week, with their Momentum scores soaring in Benzinga's Ed...

 alector-raises-fy2025-sales-guidance-from-5000m-15000m-to-13000m-18000m-vs-12114m-est

Alector (NASDAQ:ALEC) raises FY2025 sales outlook from $5.000 million-$15.000 million to $13.000 million-$18.000 million vs $12...

 alector-q2-eps-030-beats-043-estimate-sales-7900m-beat-2750m-estimate

Alector (NASDAQ:ALEC) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.43) by 29...

 mizuho-upgrades-alector-to-outperform-raises-price-target-to-35

Mizuho analyst Graig Suvannavejh upgrades Alector (NASDAQ:ALEC) from Neutral to Outperform and raises the price target from ...

 alector-announces-neil-berkley-appointed-interim-chief-financial-officer-succeeding-marc-grasso-effective-june-20-2025

-- Neil Berkley, M.B.A., appointed Interim Chief Financial Officer, succeeding Marc Grasso, M.D., effective June 20, 2025 --SOU...

 hc-wainwright--co-maintains-buy-on-alector-raises-price-target-to-10

HC Wainwright & Co. analyst Andrew Fein maintains Alector (NASDAQ:ALEC) with a Buy and raises the price target from $7 t...

 alector-q1-eps-041-beats-048-estimate-sales-367m-miss-438m-estimate

Alector (NASDAQ:ALEC) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.48) by 14...

 morgan-stanley-assumes-alector-at-underweight-lowers-price-target-of-15

Morgan Stanley analyst Sean Laaman assumes Alector (NASDAQ:ALEC) with a Underweight rating and lowers Price Target of $1.5.

 hc-wainwright--co-reiterates-buy-on-alector-maintains-7-price-target

HC Wainwright & Co. analyst Andrew Fein reiterates Alector (NASDAQ:ALEC) with a Buy and maintains $7 price target.

 alector-sees-fy2025-collaboration-revenue-to-be-between-5-million-and-15-million

Alector (NASDAQ:ALEC) sees FY2025 sales of $5.000 million-$15.000 million vs $62.89 million analyst estimate.

 alector-q4-2024-gaap-eps-002-up-from-049-yoy-sales-54240m-beat-16621m-estimate

Alector (NASDAQ:ALEC) reported quarterly losses of $(0.02) per share. This is a 95.92 percent increase over losses of $(0.49) p...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION